Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
Williams
G M
GM
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced; D016889:Endometrial Neoplasms / Q000139:chemically induced*; D004958:Estradiol / Q000009:adverse effects / Q000031:analogs & derivatives*; D004965:Estrogen Antagonists / Q000009:adverse effects*; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D051379:Mice; D009376:Neoplasms, Hormone-Dependent / Q000139:chemically induced*; D013629:Tamoxifen / Q000009:adverse effects*; D017312:Toremifene / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen; D000077267:Fulvestrant; D004958:Estradiol; D017312:Toremifene